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Aim of the study
Liver metastases from carcinoma of the colon-rectum
(CCR) develop in about 50% of patients undergoing
resection of primary tumor and about 15–25% of patients
had synchronous metastases at presentation. In the
absence of surgical treatment, survival 1 year after diagno-
sis is 30% and is less than 5% at 5 years. The 5-year sur-
vival after resection varies from 20 to 54%, while the value
of post-operative mortality is currently less than 5%.
Resection should be considered for all patients with dis-
ease confined to the liver where there is a real possibility
of radical resection and maintaining a proper liver func-
tion. Currently, the average age of patients undergoing
resection is over 60 years. At the same time we are witness-
ing an expansion of that surgery in patients older than 70
years. This retrospective work is to evaluate whether age
may be a limit to liver surgery, and which clinical-patho-
logical factors are predictive of outcome in the medium to
long term.
Materials and methods
140 patients resected for liver metastases from CCR
between 1990 and 2007. For statistical purposes, the
series was divided into two groups according to age:
Group 1 ≥70 years (36/140), group 2 <70 years (104/
140). Survival was calculated by the Kaplan-Meier
method, differences between variables were estimated by
the Log-rank test. Multivariate analysis was applied to
analyze independent factors affecting survival. Data
processing was performed using SPSS 13.0 for Windows
Evaluation Version (SPSS Inc., Chicago, IL, USA).
Results
The average age of the whole series was of 61.4 years.
Overall, there were 158 major procedures, 12 of which
were repeated resections. Metastases were synchronous in
60 cases: 18 patients (50%) of group 1 and 42 (40.4%) in
the 2nd group. Co-morbidity occurred in 37 cases: 16
(11.4%) over 70 years and 27 (19.2%) under 70 years (p
< 0.03). The ASA classification was similar in both groups.
The duration of follow-up was 31.92 ± 29.6 months
(range: 25–141 months) in the first group and 41.21 ±
45.43 (range: 6–72 months) in the group younger than 70
years.
Type of liver resection, survival and complications: a total
of 11 major resection (30.5%) and 25 minor procedures
(69.4%) were performed in the first group, and 32 major
(29.1%) and 78 minor resections (70.9%) in the second
group. Wedge resections was most performed in both
groups (30.5% over 70 vs. 35.5% under 70). Peri-opera-
tive mortality of the entire series was 1.4% (2 cases both
in group 2). The rate of complications was 30.5% in group
1 and 23.1% in group 2 (NS). Long term survival and
relapse: liver relapse accounted for 61% of patients in the
1st group (22/36), and 55.8% of the second group (58/
104). In one case of the second group (0.96%) relapse
involved the lung. Actuarial survival at 1, 3 and 5 years
was 68%, 43%, 20.3% for group 1 and respectively
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90.6%, 56% and 36.9% for group 2(p = 0.03). Multivari-
ate analysis showed as negative predictive factors: type of
resections (major resection), hepatic lymph node involve-
ment, of metastases >to 5, and diameter of the lesion ≥5
cm.
Conclusion
In this series long term survival was better for young
patients. Peri-operative mortality was 2 cases (1.9%) in
the 2nd group, and 0 in patients older than 70 years. Most
patients had post-operative course without significant
morbidity and the rate of complications was similar in
both groups. In conclusion age is not a prognostic factor
influencing the outcome in the medium term and thus is
not a contraindication to resection for liver metastases.Page 2 of 2
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